New AI tool uses gene activity patterns to predict cancer spread, helping doctors identify high-risk patients and personalize ...

The best shot at curing cancer is catching it early, doctors say, but that doesn't always happen. Between 80% and 85% of pancreatic cancer cases aren't diagnosed until the aggressive and lethal ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among women of African ancestry. This is often due to a combination of factors, ...

CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer CLAIRITY BREAST analyzes subtle imaging features on screening mammograms that ...

eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...

Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...

Re-prompting for ESR1 mutations in breast cancer: Improving mutation reporting and therapeutic decision-making. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This ...

Artificial intelligence is transforming breast cancer screening by uncovering novel mammographic features linked to risk, paving the way for more precise prevention and risk-reducing strategies. Study ...

Low-dose computed tomography (LDCT) screening is effective in reducing lung cancer mortality by detecting the disease at earlier, more treatable stages. However, high false-positive rates and the ...